|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4184 | (2006.01) |
| A61K 31/4184 | (2013.01) | ||
| A61K 47/10 | (2006.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 47/20 | (2013.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3533447 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19151152.6 |
| Date of filing the European patent application | 2013-03-15 | |
| (97) | Date of publication of the European application | 2019-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261613173 P | 2012-03-20 | US | |
| 201261669889 P | 2012-07-10 | US | |
| 201261678715 P | 2012-08-02 | US |
| (72) |
SUNDARAM, Srikanth , US
TARRIFF, Scott, L. , US
|
| (73) |
Eagle Pharmaceuticals, Inc. ,
50 Tice Boulevard
Suite 315, Woodcliff Lake, NJ 07677,
US
|
| (54) | BENDAMUSTINE LIQUID COMPOSITIONS FOR USE IN METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION |
| BENDAMUSTINE LIQUID COMPOSITIONS FOR USE IN METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION |